SCHEMBL647162

SCHEMBL647162

CS(=O)(=O)c1ccc(O)c(N=Nc2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.57
MEN1 O00255 6/20 0.57
KMT2A Q03164 6/20 0.57
ALDH1A1 P00352 5/20 0.57
POLB P06746 3/20 0.57
NPSR1 Q6W5P4 2/20 0.57
HTT P42858 2/20 0.57
LMNA P02545 1/20 0.57
TDP1 Q9NUW8 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
NPC1 O15118 2/20 0.47
MAPK1 P28482 2/20 0.47
RAB9A P51151 2/20 0.47
HSP90AA1 P07900 1/20 0.47
RECQL P46063 1/20 0.47
AMY1A P0DUB6 3/20 0.46
CDK1 P06493 2/20 0.45
CDK2 P24941 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10156289 1.00 MAPT (0.57) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL14363017 0.86 CA1 (0.46) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL1276291 0.84 ALDH1A1 (0.68) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL1276292 0.84 ALDH1A1 (0.68) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL11553504 0.82 MAPT (0.61) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL28260564 0.82 MAPT (0.61) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL647313 0.81 FTO (0.59) MAPTMEN1KMT2APOLBTDP1
SCHEMBL647314 0.81 FTO (0.59) MAPTMEN1KMT2APOLBTDP1
SCHEMBL10156264 0.78 ALDH1A1 (0.57) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL10156271 0.78 ALDH1A1 (0.57) MAPTMEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119778-B2 Reversibly thermochromic compositions BASF SE (DE) 2012-02-21 US disclosed
EP-2032370-B1 REVERSIBLY THERMOCHROMIC COMPOSITIONS BASF SE (DE) 2010-11-10 EP disclosed
US-20100234494-A1 Reversibly thermochromic compositions CIBA CORPORATION 2010-09-16 US disclosed
EP-2032370-A2 REVERSIBLY THERMOCHROMIC COMPOSITIONS Ciba Holding Inc. (CH) 2009-03-11 EP disclosed
WO-2007147843-A2 REVERSIBLY THERMOCHROMIC COMPOSITIONS CIBA HOLDING INC. (CH) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234494-A1 Reversibly thermochromic compositions CRY1, REL, CRY2 MAPT 59/4885MEN1 937/4885KMT2A 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.